Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection
Clinical trial NCT01753323 · COMPLETED
Trial details
- NCT number
- NCT01753323
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.